Keramatian, Kamyar http://orcid.org/0000-0003-4958-6025
Chakrabarty, Trisha
DuBow, Anais
Saraf, Gayatri http://orcid.org/0000-0002-9767-2270
Yatham, Lakshmi N.
Article History
Accepted: 3 April 2023
First Online: 25 May 2023
Change Date: 12 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40265-024-02005-8
Declarations
:
: There are no sources of funding related to the preparation of this manuscript.
: Kamyar Keramatian has served on the scientific advisory board of AbbVie and is also supported by the Vancouver Coastal Health Research Institute Investigator Award. Trisha Chakrabarty has received grant funding from the Michael Smith Foundation and National Research Council-Canada. Anais DuBow and Gayatri Saraf report no conflicts of interest that might be relevant to the contents of this manuscript. Lakshmi N Yatham is a consultant and/or has received speaker fees and/or sits on the advisory board and/or receives research funding from Abbvie, Alkermes, Allergan, Canadian Network for Mood and Anxiety Treatments (CANMAT), Canadian Institutes of Health Research (CIHR), Dainippon Sumitomo Pharma, Gedeon Richter, GSK, Intracellular Therapies, Lundbeck, Merck, Otsuka, Sanofi and Sunovion over the past 3 years.
: Not applicable.
: Not applicable.
: Not applicable.
: No datasets were generated or analysed during the current study.
: Not applicable
: All authors have contributed to the concept, acquisition and interpretation of data, or critical revisions of the manuscript. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.